                         SEQUENCE LISTING

<110>  COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
	LEONETTI Michel
	SAVATIER Alexandra
	GADZINSKI Adeline
	BOULAIN Jean-Claude
	
 
<120>  COMPLEXE MOLECULAIRE DE CIBLAGE DES ANTIGENES VERS LES CELLULES 
       PRESENTATRICES D'ANTIGENE ET SES APPLICATIONS POUR LA VACCINATION

<130>  263FR373

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  artificial sequence

<220>
<223>  HIV-1 Tat 49-57 peptide (basic region)

<400>  1

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  2
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  penetratin peptide : Antennapedia protein homeodomain peptide 
       43-58

<400>  2

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  3
<211>  116
<212>  PRT
<213>  artificial sequence

<220>
<223>  ZZ derivative of S.aureus Protein A BB domain

<400>  3

Val Asp Asn Lys Phe Asn Lys Glu Gln Gln Asn Ala Phe Tyr Glu Ile 
1               5                   10                  15      


Leu His Leu Pro Asn Leu Asn Glu Glu Gln Arg Asn Ala Phe Ile Gln 
            20                  25                  30          


Ser Leu Lys Asp Asp Pro Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ala Gln Ala Pro Lys Val Asp Asn Lys Phe Asn 
    50                  55                  60                  


Lys Glu Gln Gln Asn Ala Phe Tyr Glu Ile Leu His Leu Pro Asn Leu 
65                  70                  75                  80  


Asn Glu Glu Gln Arg Asn Ala Phe Ile Gln Ser Leu Lys Asp Asp Pro 
                85                  90                  95      


Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala Lys Lys Leu Asn Asp Ala 
            100                 105                 110         


Gln Ala Pro Lys 
        115     


<210>  4
<211>  116
<212>  PRT
<213>  artificial sequence

<220>
<223>  S. aureus Protein A BB domain

<400>  4

Ala Asp Asn Lys Phe Asn Lys Glu Gln Gln Asn Ala Phe Tyr Glu Ile 
1               5                   10                  15      


Leu His Leu Pro Asn Leu Asn Glu Glu Gln Arg Asn Gly Phe Ile Gln 
            20                  25                  30          


Ser Leu Lys Asp Asp Pro Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala 
        35                  40                  45              


Lys Lys Leu Asn Asp Ala Gln Ala Pro Lys Ala Asp Asn Lys Phe Asn 
    50                  55                  60                  


Lys Glu Gln Gln Asn Ala Phe Tyr Glu Ile Leu His Leu Pro Asn Leu 
65                  70                  75                  80  


Asn Glu Glu Gln Arg Asn Gly Phe Ile Gln Ser Leu Lys Asp Asp Pro 
                85                  90                  95      


Ser Gln Ser Ala Asn Leu Leu Ala Glu Ala Lys Lys Leu Asn Asp Ala 
            100                 105                 110         


Gln Ala Pro Lys 
        115     


<210>  5
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  HIV-1 Tat 38-48 peptide (core region)

<400>  5

Phe Thr Lys Lys Gly Leu Gly Ile Ser Tyr Gly 
1               5                   10      


<210>  6
<211>  154
<212>  PRT
<213>  artificial sequence

<220>
<223>  Diphteria Toxin R domain named DTR or DTR-BD

<400>  6

Pro Gly His Lys Thr Gln Pro Phe Leu His Asp Gly Tyr Ala Val Ser 
1               5                   10                  15      


Trp Asn Thr Val Glu Asp Ser Ile Ile Arg Thr Gly Phe Gln Gly Glu 
            20                  25                  30          


Ser Gly His Asp Ile Lys Ile Thr Ala Glu Asn Thr Pro Leu Pro Ile 
        35                  40                  45              


Ala Gly Val Leu Leu Pro Thr Ile Pro Gly Lys Leu Asp Val Asn Lys 
    50                  55                  60                  


Ser Lys Thr His Ile Ser Val Asn Gly Arg Lys Ile Arg Met Arg Cys 
65                  70                  75                  80  


Arg Ala Ile Asp Gly Asp Val Thr Phe Cys Arg Pro Lys Ser Pro Val 
                85                  90                  95      


Tyr Val Gly Asn Gly Val His Ala Asn Leu His Val Ala Phe His Arg 
            100                 105                 110         


Ser Ser Ser Glu Lys Ile His Ser Asn Glu Ile Ser Ser Asp Ser Ile 
        115                 120                 125             


Gly Val Leu Gly Tyr Gln Lys Thr Val Asp His Thr Lys Val Asn Ser 
    130                 135                 140                 


Lys Leu Ser Leu Phe Phe Glu Ile Lys Ser 
145                 150                 


<210>  7
<211>  21
<212>  PRT
<213>  artificial sequence

<220>
<223>  HIV-1 Tat 37-57 peptide (core and basic regions)

<400>  7

Cys Phe Thr Lys Lys Gly Leu Gly Ile Ser Tyr Gly Arg Lys Lys Arg 
1               5                   10                  15      


Arg Gln Arg Arg Arg 
            20      


<210>  8
<211>  101
<212>  PRT
<213>  artificial sequence

<220>
<223>  HIV-1 Tat  consensus sequence

<400>  8

Met Glu Pro Val Asp Pro Lys Leu Glu Pro Trp Lys His Pro Gly Ser 
1               5                   10                  15      


Gln Pro Lys Thr Ala Cys Asn Asn Cys Tyr Cys Lys Lys Cys Cys Phe 
            20                  25                  30          


His Cys Gln Val Cys Phe Thr Lys Lys Gly Leu Gly Ile Ser Tyr Gly 
        35                  40                  45              


Arg Lys Lys Arg Arg Gln Arg Arg Arg Ala Pro Gln Asp Ser Gln Thr 
    50                  55                  60                  


His Gln Val Ser Leu Ser Lys Gln Pro Ala Ser Gln Pro Arg Gly Asp 
65                  70                  75                  80  


Pro Thr Gly Pro Lys Glu Ser Lys Lys Lys Val Glu Arg Glu Thr Glu 
                85                  90                  95      


Thr Asp Pro Val Asp 
            100     


<210>  9
<211>  60
<212>  PRT
<213>  Naja nigricollis

<400>  9

Leu Lys Cys Asn Gln Leu Ile Pro Pro Phe Trp Lys Thr Cys Pro Lys 
1               5                   10                  15      


Gly Lys Asn Leu Cys Tyr Lys Met Thr Met Arg Ala Ala Pro Met Val 
            20                  25                  30          


Pro Val Lys Arg Gly Cys Ile Asp Val Cys Pro Lys Ser Ser Leu Leu 
        35                  40                  45              


Ile Lys Tyr Met Cys Cys Asn Thr Asp Lys Cys Asn 
    50                  55                  60  


<210>  10
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  ovalbulmine T CD8+ epitope

<400>  10

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210>  11
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  ovalbuline T CD8+ epitope flanking sequence

<400>  11

Leu Glu Gln Leu Glu 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  ovalbuline T CD8+ epitope flanking sequence

<400>  12

Thr Glu Trp Thr Ser 
1               5   


<210>  13
<211>  13
<212>  PRT
<213>  artificial sequence

<220>
<223>  ovalbumine T CD4+ epitope

<400>  13

Ser Tyr Lys Lys Val Trp Arg Asp His Arg Gly Thr Ile 
1               5                   10              


<210>  14
<211>  11
<212>  PRT
<213>  artificial sequence

<220>
<223>  HIV-1 Tat 47-57 peptide (basic region)

<400>  14

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


